Open AccessAcquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor — an update on neuroendocrine neoplasm’s treatment: A case report
Author(s) -
Oriol Mirallas,
Nadia Saoudi,
D. Gómez-Puerto,
Mar RiveiroBarciela,
Xavier Merino,
Cristina Auger,
Stefania Landolfi,
L. Blanco,
Amparo García-Burillo,
Xavier Molero,
María Teresa Salcedo-Allende,
Jaume Capdevila
Publication year - 2021
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v13.i5.611
Subject(s) - medicine , neuroendocrine tumors , pathology , neoplasm , neuroendocrine carcinoma , degeneration (medical) , oncology , immunohistochemistry
Metastatic small bowel low-grade neuroendocrine tumors (NETs) have a good prognosis. Surgery is the only curative treatment; however, this may induce advanced liver disease, particularly in long-term survivor patients. Acquired hepatocerebral degeneration or Parkinsonism in cirrhosis is characterized by rapidly progressive extrapyramidal symptoms in patients with advanced liver disease.